BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36924681)

  • 1. Longitudinal changes in surface based brain morphometry measures in amnestic mild cognitive impairment and Alzheimer's Disease.
    Bachmann T; Schroeter ML; Chen K; Reiman EM; Weise CM;
    Neuroimage Clin; 2023; 38():103371. PubMed ID: 36924681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Reserve Modulates Brain Structure and Cortical Architecture in the Alzheimer's Disease.
    Serra L; Giancaterino G; Giulietti G; Petrosini L; Di Domenico C; Marra C; Caltagirone C; Bassi A; Cercignani M; Bozzali M
    J Alzheimers Dis; 2022; 89(3):811-824. PubMed ID: 35964192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI.
    Ezzati A; Zammit AR; Habeck C; Hall CB; Lipton RB;
    Brain Imaging Behav; 2020 Oct; 14(5):1792-1804. PubMed ID: 31104279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Vipin A; Loke YM; Liu S; Hilal S; Shim HY; Xu X; Tan BY; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2018 Aug; 10(1):82. PubMed ID: 30121086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease.
    Förster S; Buschert VC; Teipel SJ; Friese U; Buchholz HG; Drzezga A; Hampel H; Bartenstein P; Buerger K
    J Alzheimers Dis; 2011; 26 Suppl 3():337-48. PubMed ID: 21971473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Fu Z; Zhao M; Wang X; He Y; Tian Y; Yang Y; Han Y; Li S
    J Alzheimers Dis; 2021; 79(3):1121-1132. PubMed ID: 33386805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.
    Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA
    Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation Between Brain Structure Atrophy and Plasma Amyloid-β and Phosphorylated Tau in Patients With Alzheimer's Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry.
    Li K; Qu H; Ma M; Xia C; Cai M; Han F; Zhang Q; Gu X; Ma Q
    Front Aging Neurosci; 2022; 14():816043. PubMed ID: 35547625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease.
    Förster S; Buschert VC; Buchholz HG; Teipel SJ; Friese U; Zach C; la Fougere C; Rominger A; Drzezga A; Hampel H; Bartenstein P; Buerger K
    J Alzheimers Dis; 2011; 25(4):695-706. PubMed ID: 21498904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and radiological profile of posterior cortical atrophy and comparison with a group of typical Alzheimer disease and amnestic mild cognitive impairment.
    Das G; Dubey S; Sinharoy U; Mukherjee A; Banerjee S; Lahiri D; Biswas A
    Acta Neurol Belg; 2021 Aug; 121(4):1009-1018. PubMed ID: 33230741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression.
    Joko T; Washizuka S; Sasayama D; Inuzuka S; Ogihara T; Yasaki T; Hagiwara T; Sugiyama N; Takahashi T; Kaneko T; Hanihara T; Amano N
    Psychogeriatrics; 2016 Nov; 16(6):355-361. PubMed ID: 26756596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
    Mah L; Binns MA; Steffens DC;
    Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative.
    Song X; Mitnitski A; Zhang N; Chen W; Rockwood K;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):71-8. PubMed ID: 23123510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated Brain MRI Volumetry Differentiates Early Stages of Alzheimer's Disease From Normal Aging.
    Zhao W; Luo Y; Zhao L; Mok V; Su L; Yin C; Sun Y; Lu J; Shi L; Han Y
    J Geriatr Psychiatry Neurol; 2019 Nov; 32(6):354-364. PubMed ID: 31480984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain MRI Biomarkers to Predict Cognitive Decline in Older People with Alzheimer's Disease.
    Zhu LY; Shi L; Luo Y; Leung J; Kwok T
    J Alzheimers Dis; 2022; 88(2):763-769. PubMed ID: 35723095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.